Tag: Hypermobile eds

Affecting connective tissue, which provides support for the body's structures, Ehlers-Danlos syndrome (EDS) is not classified as a classic degenerative disease. However, understanding its progression over time is crucial as symptoms can become more pronounced and complicated with age. This makes the question 'Is Ehlers-Danlos syndrome a degenerative disease?' complex for patients and clinicians alike.

As a genetic disorder affecting connective tissues, Ehlers-Danlos syndrome (EDS) can impact virtually every organ system in the body. The widespread nature of connective tissue—the 'glue' that supports and structures all our organs—explains why a defect in its formation leads to a diverse range of complications, affecting more than just the skin and joints. A deeper understanding of **what organs are affected by EDS** is crucial for patients and clinicians alike to manage this complex condition effectively.

Studies suggest that a significant percentage of people with hypermobile Ehlers-Danlos Syndrome (hEDS) also experience Postural Orthostatic Tachycardia Syndrome (POTS), making it a well-documented answer to the question of **what is a common comorbidity with EDS**. This connection is so prevalent that it is often discussed alongside Mast Cell Activation Syndrome (MCAS) as part of a classic trio of co-occurring conditions.

The effect of Ehlers-Danlos syndrome (EDS) on longevity is not uniform across all cases, as it depends on the specific type of the genetic connective tissue disorder. Most common types do not affect a person's lifespan, while rarer forms carry a risk of life-threatening complications that can shorten it. Understanding **what is Ehlers-Danlos syndrome life expectancy?** means examining the varied prognoses associated with each subtype.